• Home
  •    |   
  • Contact Us
Semprus
     

  • About Us  
    • Company Background
    • Leadership
    • Scientific Advisory Board
    • Current Investors
    • Code of Ethics
    • Affiliations and
      Associations
    • Contact Us
  • |

  •   Market Overiew  
    • Semprus Platform
    • Market Dynamics
  • |

  •   Vascular Access  
    • Semprus Sustain™ Technology
  • |

  •   Future Applications  
    • Pipeline
  • |

  •  Media
Delivering paradigm-shifting medical technologies to improve patient outcomes and reduce complications associated with medical device implants.

Facebook Twitter LinkedIn

NEWS

Teleflex Receives FDA 510(k) Clearance for Nylus PICC with Semprus Sustain Technology
(news article)


Semprus BioSciences Awarded U.S. Army Grant To Develop Anti-Biofilm Endotracheal Tube
(news article)


Semprus BioSciences research published in Science Translational Medicine Journal
(journal article)

(press package)


Semprus CTO Comments on Biofilm-Resistant Polymers on Implantable Devices
(news article)

Semprus Selected as One of  “50 Companies To Watch” in MD+DI Magazine


©2012 Semprus BioSciences
  • Terms of Service
  • |
  • Site Map